Yuwei Zhang

Prof. Dr. Yuwei Zhang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
YLYuying Li Li
Yuying Li Li
XYXinmin Yang
Xinmin Yang
LPLinrui Peng
Linrui Peng
QXQing Xia
Qing Xia
YZYuwei Zhang
Yuwei Zhang
Da JiaDa Jia
Da Jia
Seipin, a protein encoded by the Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2) gene, is famous for its key role in the biogenesis of lipid droplets and type 2 congenital generalised lipodystrophy (CGL2). BSCL2 gene mutations result in genetic diseases including CGL2, progressive encephalopathy with or without lipodystrophy (also called Celia’s encephalopathy), and BSCL2-associated motor neuron diseases. Abnormal expression of seipin has also been found in hepatic steatosis, neurodegenerative diseases, glioblastoma stroke, cardiac hypertrophy, and other diseases. In the current study, we comprehensively summarise phenotypes, underlying mechanisms, and treatment of human diseases caused by BSCL2 gene mutations, paralleled by animal studies including systemic or specific Bscl2 gene knockout, or Bscl2 gene overexpression. In various animal models representing diseases that are not related to Bscl2 mutations, differential expression patterns and functional roles of seipin are also described. Furthermore, we highlight the potential therapeutic approaches by targeting seipin or its upstream and downstream signalling pathways. Taken together, restoring adipose tissue function and targeting seipin-related pathways are effective strategies for CGL2 treatment. Meanwhile, seipin-related pathways are also considered to have potential therapeutic value in diseases that are not caused by BSCL2 gene mutations.

22 November 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
YHYuchen Hu
Yuchen Hu
LPLinrui Peng
Linrui Peng
XZXinyu Zhuo
Xinyu Zhuo
CYChan Yang
Chan Yang
YZYuwei Zhang
Yuwei Zhang
Hedgehog (Hh) signaling is a well-established developmental pathway; it is crucial for early embryogenesis, cell differentiation, and damage-driven regeneration. It is being increasingly recognized that dysregulated Hh signaling is also involved in fibrotic diseases, which are characterized by excessive extracellular matrix deposition that compromises tissue architecture and function. As in-depth insights into the mechanisms of Hh signaling are obtained, its complex involvement in fibrosis is gradually being illuminated. Notably, some Hh-targeted inhibitors are currently under exploration in preclinical and clinical trials as a means to prevent fibrosis progression. In this review, we provide a concise overview of the biological mechanisms involved in Hh signaling. We summarize the latest advances in our understanding of the roles of Hh signaling in fibrogenesis across the liver, kidneys, airways, and lungs, as well as other tissues and organs, with an emphasis on both the shared features and, more critically, the distinct functional variations observed across these tissues and organs. We thus highlight the context dependence of Hh signaling, as well as discuss the current status and the challenges of Hh-targeted therapies for fibrosis.

30 August 2025 in Molecular Aspects of Medicine
Verified
Journal Article
Closed access
LZLing Zhong
Ling Zhong
LWLiu Wang
Liu Wang
JSJibran Nehal Syed
Jibran Nehal Syed
JYJielin Yang
Jielin Yang
YZYuwei Zhang
Yuwei Zhang

12 November 2016 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YLYulan Liu
Yulan Liu
YZYuwei Zhang
Yuwei Zhang
Yanjie ZhangYanjie Zhang
Yanjie Zhang
JZJinlong Zhang
Jinlong Zhang
YLYin Liu
Yin Liu
ZSZhiguang Su
Zhiguang Su

2 February 2024 in Macromolecular Rapid Communications
Verified
Journal Article
Closed access
LPLinrui Peng
Linrui Peng
WLWei Li
Wei Li
GPGe Peng
Ge Peng
DWDanfeng Wei
Danfeng Wei
LGLiping Gou
Liping Gou
YZYuwei Zhang
Yuwei Zhang

7 July 2023 in Frontiers in Genetics
Verified
Journal Article
Open access
GRGuocheng Rao
Guocheng Rao
XPXi Peng
Xi Peng
YTYan Tian
Yan Tian
XFXianghui fu, Fu
Xianghui fu, Fu
YZYuwei Zhang
Yuwei Zhang
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death worldwide. Both genetic and environmental factors through a multitude of underlying molecular mechanisms participate in the pathogenesis of HCC. Recently, numerous studies have shown that circular RNAs (circRNAs), an emerging class of non-coding RNAs characterized by the presence of covalent bonds linking 3’ and 5’ ends, play an important role in the initiation and progression of cancers, including HCC. In this review, we outline the current status of the field of circRNAs, with an emphasis on the functions and mechanisms of circRNAs in HCC and its microenvironment. We also summarize and discuss recent advances of circRNAs as biomarkers and therapeutic targets. These efforts are anticipated to throw new insights into future perspectives about circRNAs in basic, translational and clinical research, eventually advancing the diagnosis, prevention and treatment of HCC.